Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 169-174

  Wen, Haojie ^a,b   Chen, Yajun ^c   Hu, Zedong ^a   Mo, Qiao ^a,d   Tang, Jinyong ^b   Sun, Chuanzheng ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d Central Hospital of Shaoyang   (China)

Author keywords

BATF2; Prognosis; Squamous cell carcinoma; Tongue

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; PROTEIN BATF2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TONGUE CARCINOMA; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADULT; AGED; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84891945906     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2863     Document Type: Article

References (17)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Shiboski CH, Schmidt BL and Jordan RC: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 103: 1843 -1849, 2005.
3. Franceschi D, Gupta R, Spiro RH and Shah JP: Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 166: 360-365, 1993.
4. Yuen AP, Lam KY, Chan AC, et al: Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am J Surg 177: 90-92, 1999.
5. Myers JN, Elkins T, Roberts D and Byers RM: Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122: 44-51, 2000.
6. Wen Y, Dai X, Wang C, et al: A retrospective clinical study of 6539 cases of malignant oral-maxillofacial tumors. Hua Xi Kou Qiang Yi Xue Za Zhi 19: 296-299, 2001 (In Chinese).
7. Goldstein DP, Bachar GY, Lea J, et al: Outcomes of squamous cell cancer of the oral tongue managed at the Princess Margaret Hospital. Head Neck 35: 632-641, 2013.
8. Su ZZ, Lee SG, Emdad L, et al: Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci USA 105: 20906 -20911, 2008.
9. Wang C, Su Y, Zhang L, et al: The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis. PLoS One 7: e38046, 2012.
10. Ma H, Liang X, Chen Y, et al: Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma. Int J Cancer 128: 771-777, 2011.
11. Liu ZB, Yang Y, Ye XG, Wang L, Tian PY and Zhang YY: Expression and significance of SARI and CCN1 in human colorectal carcinomas. Zhonghua Yi Xue Za Zhi 91: 2397-2401, 2011 (In Chinese).
12. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A (eds): AJCC Cancer Staging Manual. 7th edition. Springer, New York, 2010.
13. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M and Sugihara K: Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 10: 8465-8471, 2004.
14. Murphy TL, Tussiwand R and Murphy KM: Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat Rev Immunol 13: 499-509, 2013.
15. Huang Q, Yang Y, Li X and Huang S: Transcription suppression of SARI (suppressor of AP-1, regulated by IFN) by BCR-ABL in human leukemia cells. Tumour Biol 32: 1191-1197, 2011.
16. Dash R, Su ZZ, Lee SG, et al: Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. Oncogene 29: 4412-4423, 2010.
17. Tussiwand R, Lee WL, Murphy TL, et al: Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490: 502-507, 2012.